Preparation and in vitro evaluation of photodynamic-responsive nanoliposome loaded PL-5

Wen Lin1, Qiong-Zhi Shi2, Xiang-Ru Liao2

  • 1Department of Clinical Laboratory, Wuhan Third Hospital (Tongren Hospital of Wuhan University), Wuhan, China.

Plos One
|June 16, 2026
PubMed

Insights

This study developed a red-light-activated liposomal system for antimicrobial peptide PL-5 to combat difficult burn wound infections. Light activation significantly boosted its effectiveness against bacteria and biofilms, offering a promising new treatment.

Area of Science:

  • Biomedical Engineering
  • Materials Science
  • Infectious Diseases

Background:

  • Burn wound infections are often caused by multidrug-resistant pathogens like MRSA.
  • Antimicrobial peptides (AMPs) show promise but face challenges like instability and poor biofilm penetration.
  • Developing advanced delivery systems is crucial for effective antimicrobial therapy.

Purpose of the Study:

  • To create a red-light-responsive liposomal system for the antimicrobial peptide PL-5.
  • To enhance the antibacterial and antibiofilm efficacy of PL-5 for burn wound infections.
  • To investigate light-triggered, localized drug delivery for improved therapeutic outcomes.

Main Methods:

  • Developed porphyrin-phospholipid (PoP)-containing cationic liposomes encapsulating PL-5.
  • Optimized liposomes for size, charge, stability, and controlled release under red light (635 nm).
  • Evaluated in vitro antimicrobial and antibiofilm activity against MRSA and MSSA.

Main Results:

  • Optimized liposomes exhibited high encapsulation efficiency (~73%) and nanoscale size (~50 nm).
  • Red-light activation significantly reduced MIC values (fourfold) and accelerated killing of MRSA and MSSA.
  • Light-activated liposomes demonstrated marked inhibition of biofilm formation.
  • Controlled release of PL-5 was achieved via red-light irradiation.

Conclusions:

  • Light-responsive liposomal delivery of PL-5 potentiates antibacterial and antibiofilm efficacy.
  • This approach enables spatiotemporally controlled peptide release for localized treatment.
  • The developed system offers a promising strategy for biofilm-associated burn wound infections.

Related Concept Videos